The effect of neuromuscular blockade on oxygen consumption in sedated and mechanically ventilated pediatric patients after cardiac surgery.
OBJECTIVE
To measure the effect of intense neuromuscular blockade (NMB) on oxygen consumption (VO(2)) in deeply sedated and mechanically ventilated children on the first day after complex congenital cardiac surgery.


METHODS
Prospective clinical interventional study.


METHODS
Pediatric intensive care unit of an university medical centre.


RESULTS
Nine mechanically ventilated and sedated children (weight 2.8-8.7 kg) were included. All children were treated with vasoactive drugs. The level of sedation was quantified using the comfort score, Ramsay score and bispectral index (BIS). The intensity of NMB was quantified using acceleromyography and VO(2) was measured using indirect calorimetry. Analgo-sedation using various intravenous agents was targeted at a deep level (comfort score < 18, BIS < 60 and Ramsay score > 4). NMB was achieved by intravenous administration of rocuronium. All measurements were conducted before, during and after recovery from a period of intense NMB. Baseline values were VO(2) 6.1 ml/(kg min) (SD 1.3), comfort score 13 (SD 0.7), BIS 42.5 (SD 14.2), mean blood pressure 54.0 mmHg (SD 10.5), mean heart rate 129.9 bpm (SD 28.9) and mean core temperature 36.7 degrees C (SD 0.5). There were no significant differences in VO(2) or other parameters between baseline, during NMB and the recovery phase.


CONCLUSIONS
Neuromuscular blocking agents do not reduce oxygen consumption in deeply sedated and mechanically ventilated children after congenital cardiac surgery.
Lemson
J
J
Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Route 551, PO Box 9101, 6500 HB Nijmegen, The Netherlands. j.lemson@ic.umcn.nl
Driessen
J J
JJ
van der Hoeven
J G
JG
D006348:Cardiac Surgical Procedures; D015331:Cohort Studies; D054810:Deep Sedation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007362:Intensive Care Units; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D010101:Oxygen Consumption / Q000187:drug effects*; D012121:Respiration, Artificial
Crit Care Med. 2000 May;28(5):1569-71
10834713
Circulation. 1975 May;51(5):867-74
235375
Crit Care Med. 1997 Jan;25(1):72-7
8989179
Crit Care Med. 1994 Jan;22(1):163-70
8124960
J Burn Care Rehabil. 1997 Sep-Oct;18(5):461-8; discussion 460
9313131
Crit Care Med. 2000 Aug;28(8):3014-8
10966288
Arch Dis Child. 2002 Feb;86(2):103-7
11827903
Crit Care. 2005 Feb;9(1):R9-17
15693968
Chest. 1996 Apr;109(4):1038-42
8635328
Intensive Care Med. 1997 Feb;23(2):201-7
9069007
Am J Respir Crit Care Med. 1995 Jan;151(1):210-4
7812556
Paediatr Anaesth. 2002 Jul;12(6):507-10
12139591
Crit Care Med. 2003 Mar;31(3):830-3
12626992
Br Med J. 1974 Jun 22;2(5920):656-9
4835444
Eur J Anaesthesiol. 2005 Jan;22(1):11-5
15816566
Anesthesiology. 1984 Nov;61(5):518-22
6496989
Intensive Care Med. 2008 Nov;34(11):2092-9
18600313
Crit Care Med. 1999 Jul;27(7):1358-68
10446832
Crit Care Med. 1988 Nov;16(11):1110-6
3048900
Crit Care Med. 2000 Apr;28(4):1166-72
10809300